Search results for “Myelodysplastic syndromes” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,588 patents, we discovered top 239 key players by total patent application. Celgene Corp., Novartis AG, Boehringer Ingelheim International GmbH are dominant in this area. They take 24.50% of the total patent filing.
Celgene Corp.
New Jersey, United States
Patent: 176
Novartis AG
Basel-Stadt, Switzerland
Patent: 138
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 75
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 68
Telik, Inc.
California, United States
Patent: 47
MacroGenics, Inc.
United States
Patent: 45
Geron Corp.
California, United States
Patent: 38
Acceleron Pharma, Inc.
Massachusetts, United States
Patent: 36
Eli Lilly & Co.
Indiana, United States
Patent: 32
Amgen, Inc.
California, United States
Patent: 31
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 43 patents, we discovered top 11 start-ups by total patent application. Forty Seven, Inc., Starton Therapeutics, Inc., ALX Oncology, Inc. are active in this area.
STARTUP
Forty Seven, Inc.
California, United States
Patent: 12
STARTUP
Starton Therapeutics, Inc.
New York, United States
Patent: 7
STARTUP
ALX Oncology, Inc.
California, United States
Patent: 5
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 4
STARTUP
Kurome Therapeutics, Inc.
Ohio, United States
Patent: 4
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 3
STARTUP
Oncoheroes Biosciences Inc
Massachusetts, United States
Patent: 3
STARTUP
Regenacy Pharmaceuticals LLC
Massachusetts, United States
Patent: 2
STARTUP
SERVIER PHARMA LLC
Massachusetts, United States
Patent: 1
STARTUP
Kling Biotherapeutics BV
Noord-Holland, Netherlands
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 595 patents applied in the last 5 years. We discover 144 most active companies in this area. The fast-growing Janssen Pharmaceutica NV, MacroGenics, Inc., Celgene Corp. take 19.83% of patent filing during this period.
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 45
MacroGenics, Inc.
United States
Patent: 43
Celgene Corp.
New Jersey, United States
Patent: 30
Geron Corp.
California, United States
Patent: 30
Novartis AG
Basel-Stadt, Switzerland
Patent: 29
Southern Research Institute
Alabama, United States
Patent: 28
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 19
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 15
Silence Therapeutics GmbH
Berlin, Germany
Patent: 15
Acceleron Pharma, Inc.
Massachusetts, United States
Patent: 13
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 595 patents in last 5 years, we discover 83 new entrants. Nottingham Trent University, Silence Therapeutics GmbH, Forty Seven, Inc. are the most active new entrants in this area.
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 19
Silence Therapeutics GmbH
Berlin, Germany
Patent: 15
STARTUP
Forty Seven, Inc.
California, United States
Patent: 12
NanoString Technologies, Inc.
Washington, United States
Patent: 11
Seagen Inc.
Washington, United States
Patent: 11
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 8
Pinotbio
undefined undefined
Patent: 8
Johnson & Johnson (China) Investment Ltd.
Shanghai Shi, China
Patent: 8
IGF Oncology LLC
Minnesota, United States
Patent: 8
Actinium Pharmaceuticals, Inc.
New York, United States
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 367 patents, we discovered top 47 universities and scientific research institutions by total patent application. Nottingham Trent University, University of Bern, Friedrich-Alexander-Universität Erlangen-Nürnberg are dominant in this area. They take 23.98% of the total patent filing.
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 19
University of Bern
Bern, Switzerland
Patent: 14
Friedrich-Alexander-Universität Erlangen-Nürnberg
Bayern, Germany
Patent: 13
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 9
University of Strasbourg
France
Patent: 8
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 7
University of Tokyo
Tokyo-to, Japan
Patent: 7
Tokai University
Tokyo-to, Japan
Patent: 7
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 7
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 6
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: